3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Waldenstrom Macroglobulinemia
1
Neoplasm, Residual
1
Interventions
zanubrutinib
3
Therapeutics
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Flow Cytometry
2
Drug Therapy
2
obinutuzumab
1
Watchful Waiting
1
Valganciclovir
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Leukapheresis
1
Indium
1
In Situ Hybridization, Fluorescence
1
Immunotherapy
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Ganciclovir
1
Foscarnet
1
Fentanyl
1
Dapsone
1
Cytogenetic Analysis
1
Cryopreservation
1
Clonal Evolution
1
Biological Therapy
1
Antiviral Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Waldenstrom Macroglobulinemia
×
Clonal Evolution
×
Clear all
NCT03521596
2025-11-18
FIL_BIOWM
Fondazione Italiana Linfomi - ETS
Completed
300 enrolled